Aytu Biopharma Inc
NASDAQ:AYTU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Aytu Biopharma Inc (AYTU) under the Base Case is 7.48 USD per share.
Compared with the current market price of 1.79 USD, the stock appears
Undervalued by 76% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Aytu Biopharma Does
Aytu Biopharma is a small specialty pharmaceutical company that sells branded medicines and pediatric health products in the United States. Its portfolio has included prescription treatments such as ADHD and allergy medicines, along with children’s vitamins and other consumer health products. The company does not try to build a broad drug pipeline; instead, it focuses on buying, licensing, and commercializing established niche products that already have a place in doctors’ offices and pharmacies.
- Headquarters
- United States of America US
- Employees
- 82
- IPO date
- Oct 20, 2017
Revenue & Expenses Breakdown
Aytu Biopharma Inc
Earnings Waterfall
Aytu Biopharma Inc
What is the Intrinsic Value of one AYTU stock?
The intrinsic value for Aytu Biopharma Inc (AYTU) under the Base Case is 7.48 USD.
Is AYTU stock undervalued or overvalued?
Compared with the current market price of 1.79 USD, the stock appears Undervalued by 76% .
